Artificial Intelligence in Disease Surveillance

The emergence of numerous infectious diseases in the twenty-first century has made it essential to monitor outbreaks quickly before they cost lives and spread throughout the community.
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

 Rapid outbreak monitoring to prevent widespread health crises 
has become necessary for the emergence of numerous infectious 
diseases, especially antimicrobial resistance. Effective disease control 
relies on surveillance methods tailored to clinical approaches and 
epidemiology, considering evolving pathogens, at-risk populations, and 
ongoing mortality and morbidity data. Drug-resistant microorganisms 
have surged, compromising treatment efficacy and threatening global 
healthcare systems. Artificial Intelligence (AI) offers transformative 
potential in healthcare and microbiology by improving diagnostic 
accuracy, expediting drug discovery, and combating antimicrobial 
resistance. AI’s rapid analysis of genetic sequences enhances pathogen 
identification, while its predictive capabilities streamline drug 
development, thus supporting global health efforts. 

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in